Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Environmental Toxicology and Pharmacology
|
June 25, 2025
The intracellular free concentration of endocrine disrupting chemicals enables translation between cell-free and cell-based estrogenic activity assays
Vesna Munic Kos, Staffan Arvidsson, Barira Islam, et al.
Communications Chemistry
|
November 14, 2025
Progress and future outlook towards a safe and sustainable production and use of chemicals
John Munthe, Lennart Bergström, Dämien Bolinius, et al.
Frontiers in Neurology
|
March 13, 2023
APRIL: A double-blind, placebo-controlled, randomized, Phase Ib/IIa clinical study of ApTOLL for the treatment of acute ischemic stroke
Macarena Hernández-Jiménez, Francisco Abad-Santos, Ian Cotgreave, et al.
ALTEX
|
November 6, 2014
The SEURAT-1 approach towards animal free human safety assessment
Tilman Gocht, Elisabet Berggren, Hans Jürgen Ahr, et al.
Analytical Biochemistry
|
July 24, 2021
Pre-validation of choriogenin H transgenic medaka eleutheroembryos as a quantitative estrogenic activity test method
Xueping Chen, Shuk Han Cheng, Masato Kinoshita, et al.
Alternatives to Laboratory Animals : ATLA
|
October 2, 2008
Barriers to validation: a report by the European Partnership fo Alternative Approaches to Animal Testing (EPAA) Working Group 5
Hans-Jürgen Ahr, Nathalie Alepée, Siegfried Breier, et al.
Environmental Health : a Global Access Science Source
|
July 15, 2016
A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals
Laura N Vandenberg, Marlene Ågerstrand, Anna Beronius, et al.
Nanoimpact
|
May 13, 2022
Blueprint for a self-sustained European Centre for service provision in safe and sustainable innovation for nanotechnology
Effie Marcoulaki, Jesús M López de Ipiña, Sven Vercauteren, et al.
JAMA Neurology
|
June 20, 2023
Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial
Macarena Hernández-Jiménez, Francisco Abad-Santos, Ian Cotgreave, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Environmental Toxicology and Pharmacology
|
June 25, 2025
The intracellular free concentration of endocrine disrupting chemicals enables translation between cell-free and cell-based estrogenic activity assays
Vesna Munic Kos, Staffan Arvidsson, Barira Islam, et al.
Communications Chemistry
|
November 14, 2025
Progress and future outlook towards a safe and sustainable production and use of chemicals
John Munthe, Lennart Bergström, Dämien Bolinius, et al.
Frontiers in Neurology
|
March 13, 2023
APRIL: A double-blind, placebo-controlled, randomized, Phase Ib/IIa clinical study of ApTOLL for the treatment of acute ischemic stroke
Macarena Hernández-Jiménez, Francisco Abad-Santos, Ian Cotgreave, et al.
ALTEX
|
November 6, 2014
The SEURAT-1 approach towards animal free human safety assessment
Tilman Gocht, Elisabet Berggren, Hans Jürgen Ahr, et al.
Analytical Biochemistry
|
July 24, 2021
Pre-validation of choriogenin H transgenic medaka eleutheroembryos as a quantitative estrogenic activity test method
Xueping Chen, Shuk Han Cheng, Masato Kinoshita, et al.
Alternatives to Laboratory Animals : ATLA
|
October 2, 2008
Barriers to validation: a report by the European Partnership fo Alternative Approaches to Animal Testing (EPAA) Working Group 5
Hans-Jürgen Ahr, Nathalie Alepée, Siegfried Breier, et al.
Environmental Health : a Global Access Science Source
|
July 15, 2016
A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals
Laura N Vandenberg, Marlene Ågerstrand, Anna Beronius, et al.
Nanoimpact
|
May 13, 2022
Blueprint for a self-sustained European Centre for service provision in safe and sustainable innovation for nanotechnology
Effie Marcoulaki, Jesús M López de Ipiña, Sven Vercauteren, et al.
JAMA Neurology
|
June 20, 2023
Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial
Macarena Hernández-Jiménez, Francisco Abad-Santos, Ian Cotgreave, et al.
Page
of 3